Benjamin Graham · Investimento deep-value defensivo
Is Xeris Biopharma Holdings, Inc. (XERS) a Benjamin Graham Stock?
Meets 2/7 Graham criteria, classic deep-value candidate.
79/100
Não encaixa
2/7 critérios atendidos
Os critérios de Benjamin Graham, aplicados a XERS
P/E ≤ 15
chave92.7x
P/B ≤ 1.5
chave85.6x
Current ratio ≥ 2
2.1x
Debt / Equity ≤ 1
2.9x
Como XERS pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$1.66B
P/L (TTM)
92.7x
ROIC (TTM)
12.84%
Margem bruta
81.59%
Outras análises Benjamin Graham
Perguntas frequentes
What is XERS's Benjamin Graham fit score?
XERS scores 79/100 on our Benjamin Graham fit engine. Meets 2/7 Graham criteria, classic deep-value candidate.
Does Benjamin Graham actually own XERS?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends XERS.
How often is this score updated?
XERS's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Benjamin Graham possua ou recomende XERS pessoalmente.
